These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29265019)

  • 41. Characteristics of outpatients in an addictions clinic for co-occurring disorders.
    Malat J; Turner NE
    Am J Addict; 2013; 22(3):297-301. PubMed ID: 23617875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comorbidity between substance use disorders and psychiatric conditions.
    Schuckit MA
    Addiction; 2006 Sep; 101 Suppl 1():76-88. PubMed ID: 16930163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Psychiatric complications of cannabis use].
    Coscas S; Benyamina A; Reynaud M; Karila L
    Rev Prat; 2013 Dec; 63(10):1426-8. PubMed ID: 24579344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study to compare the differences between genders in psychiatric comorbidities in individuals with psychoses.
    Das P; Sreedaran P; Mv A
    Asian J Psychiatr; 2018 Feb; 32():84-88. PubMed ID: 29220783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substance use disorders among treatment naïve first-episode psychosis patients.
    Chand P; Thirthalli J; Murthy P
    Compr Psychiatry; 2014 Jan; 55(1):165-9. PubMed ID: 24183888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurobiology of Comorbid Substance Use Disorders and Psychiatric Disorders: Current State of Evidence.
    Singh Balhara YP; Patnaik Kuppili P; Gupta R
    J Addict Nurs; 2017; 28(1):E1-E2. PubMed ID: 28252513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-morbidity of select anxiety, affective, and psychotic disorders with cannabis dependence in Southwest California Indians.
    Gilder DA; Lau P; Dixon M; Corey L; Phillips E; Ehlers CL
    J Addict Dis; 2006; 25(4):67-79. PubMed ID: 17088227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comorbidity of Axis I and II mental disorders with schizophrenia and psychotic disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    McMillan KA; Enns MW; Cox BJ; Sareen J
    Can J Psychiatry; 2009 Jul; 54(7):477-86. PubMed ID: 19660170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. State psychiatric hospital patients with past arrests for violent crimes.
    Grossman LS; Haywood TW; Cavanaugh JL; Davis JM; Lewis DA
    Psychiatr Serv; 1995 Aug; 46(8):790-5. PubMed ID: 7583479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.
    Nielsen SM; Toftdahl NG; Nordentoft M; Hjorthøj C
    Psychol Med; 2017 Jul; 47(9):1668-1677. PubMed ID: 28166863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Review of Digital Interventions to Decrease Cannabis Use Among Patients With Comorbid Psychiatric Disorders.
    Whiteley L; Olsen EM; Haubrick KK; Kang C; Vaughan I; Brown LK
    J Dual Diagn; 2022; 18(4):199-210. PubMed ID: 36178356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.
    Dekker N; Meijer J; Koeter M; van den Brink W; van Beveren N; Kahn RS; Linszen DH; van Os J; Wiersma D; Bruggeman R; Cahn W; de Haan L; Krabbendam L; Myin-Germeys I;
    Psychol Med; 2012 Sep; 42(9):1903-11. PubMed ID: 22452790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    J Clin Psychiatry; 2014 Apr; 75(4):349-56. PubMed ID: 24813404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabis as a risk factor for psychosis: systematic review.
    Semple DM; McIntosh AM; Lawrie SM
    J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study.
    Eack SM; Hogarty SS; Bangalore SS; Keshavan MS; Cornelius JR
    J Dual Diagn; 2016; 12(1):74-82. PubMed ID: 27089154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychoses and illicit drug use: need for cross-cultural studies.
    Thirthalli J; Venkatesh BK; Gangadhar BN
    Acta Psychiatr Scand; 2008 Jul; 118(1):86; author reply 86-7. PubMed ID: 18489616
    [No Abstract]   [Full Text] [Related]  

  • 59. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of illegal substance use on cognitive function in individuals with a psychotic disorder: a review and meta-analysis.
    Donoghue K; Doody GA
    Neuropsychology; 2012 Nov; 26(6):785-801. PubMed ID: 22924618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.